Researchers Under the Scope
Miniature human brains grown in a Saskatoon lab are upending the way researchers see neurology and immunology. Neuroscientist is using brain organoids to challenge decades of rodent-based research, charting a new course for precision medicine. As a high school biology teacher, Wenzel's students learned how hearts pump blood and lungs move air. But apart from neurological electrical activity, neither Wenzel nor the textbooks had many clear answers about the brain. During his graduate studies, Wenzel realized the same experimental question tended to produce opposite results for...
info_outlineResearchers Under the Scope
As Researchers Under the Scope marks its 100th episode, we hand the microphone to Dr. Linda Chelico, who recently accepted a five-year term as Vice-Dean Research, Biomedical Sciences, at the University of Saskatchewan’s College of Medicine. Originally from Melfort, Saskatchewan, the virologist and biochemist outlines her two main priorities: upgrading research infrastructure and raising the public profile of her colleagues’ work. Since the Covid-19 pandemic, Chelico said biomedical researchers are now expected to team up producing multiple lines of...
info_outlineResearchers Under the Scope
Dr. Holly Graham never planned on nursing. She wanted a police badge, then a law degree and a judge’s bench. Instead, she followed her mother’s wish and walked into nursing school as the only student from a reserve in a class of more than 200. The isolation was real. So were the health gaps she saw every shift. In this episode, Graham traces her path from being the only Cree nurse in her graduating class, to becoming a professor of psychiatry, registered doctoral psychologist, and . Her curiosity about widespread health disparities for Indigenous people pushed her back to university,...
info_outlineResearchers Under the Scope
Most childhoods don’t involve sitting at the hospital for an infusion of medication, transfusions on weekends, or worrying that classmates will comment on the colour of your skin. For one Saskatoon teen with an ultra-rare blood disease, that’s everyday life. She was diagnosed with a form of anemia so uncommon only a handful of cases have been identified globally. In this episode, & share how they’re working to change her “normal” by opening a phase 3 pharmaceutical trial and fighting for a better quality of life. We hear how Tehseen and Felton each got into...
info_outlineResearchers Under the Scope
Peter Hedlin (PhD, MD) recalls being a ‘young, naïve medical student’ when he asked a mentor a question that’s stuck with him for years. “I remember asking how anaesthetics work on the brain,” said Hedlin. “And he said, ‘we actually don’t really know’. And I thought that was crazy.” Today, at the University of Saskatchewan’s College of Medicine. He examines what surgery and sedation do to the human body — in particular, to aging brains. Trained first as a microbiologist who earned his PhD as a vaccine researcher at , Hedlin was always drawn to medicine. He...
info_outlineResearchers Under the Scope
In this episode, medical student and researcher shares what large provincial datasets reveal about opioid use disorder, maternal mental health, and pregnancy. Armed with data, she hopes better support —before, during, and after birth—can change outcomes for mothers and babies. Lanke spent her summer working with epidemiologist and the Saskatchewan Population Health and Evaluation Research Unit on a pan-Canadian project tracking opioid use in perinatal populations across five provinces. “The question we set out to answer was: What is the association between...
info_outlineResearchers Under the Scope
As a student, Jack Walther's friends often came to him when they needed a listening ear, or help with relationship struggles. This summer, Walther took his fascination with the brain and mood disorders to , learning to untangle some of the tiny molecular threads that might explain why depression so often shows up alongside dementia. Walther and the research team dug into the physical interactions between serotonin and the beta amyloid peptides that build up in patients with Alzheimer's disease. . He admits going from the classroom to the laboratory felt like a sharp learning curve. "It was...
info_outlineResearchers Under the Scope
Eve Simpson knows from experience scientific research doesn’t always follow a linear path. In the first of three student research episodes, the fourth-year biochemistry, microbiology and immunology student looks back at a summer spent decoding Eastern Equine Encephalitis Virus (EEEV) in ’s lab. Simpson said she loved doing bench research, but felt frustrated in the moments where she hit setbacks and moments of doubt. “I felt like I was letting everyone down,” she said. “But everyone I spoke to said they'd been through that. It's part of being a researcher. That's what drives us to do...
info_outlineResearchers Under the Scope
Jessica Sheldon (PhD) is on a mission to starve out Acinetobacter baumannii —one of the world’s most virulent hospital-borne pathogens. Notorious for its speedy evolution and multi-drug resistance, the hospital-borne bacteria lingers on dry surfaces and infects critically-ill patients, leading to sepsis, pneumonia and high mortality rates. In this episode, delves into the real-life events that drove her to investigate histamine, and its role in bacterial survival and immune response. In 2022, Sheldon joined the University of Saskatchewan’s College of Medicine as an assistant professor...
info_outlineResearchers Under the Scope
Kirk Haan graduated from high school, thinking he’d study pharmacy at the University of Saskatchewan, and walk out five years later. After one summer at a pharmacy, Haan realized he was after a more ‘hands-on’ career in medicine. “I’ve kind of worked with my hands my whole life, just between rummaging around on a farm and always kind of building things,” he said. “Now it’s using them to help people in a direct way.” Then, Haan found his passion — inside the laboratory. In 2018, Haan landed a summer position in , studying osmoregulation — the mechanisms that govern...
info_outlineMiniature human brains grown in a Saskatoon lab are upending the way researchers see neurology and immunology. Neuroscientist Dr. Tyler Wenzel is using brain organoids to challenge decades of rodent-based research, charting a new course for precision medicine.
As a high school biology teacher, Wenzel's students learned how hearts pump blood and lungs move air. But apart from neurological electrical activity, neither Wenzel nor the textbooks had many clear answers about the brain.
During his graduate studies, Wenzel realized the same experimental question tended to produce opposite results for mice and humans. The key difference, he found, lay in how each species' responded to toxins and injury, leaving him skeptical of neurological therapies tested on rodents.
Now an assistant professor of psychiatry at the University of Saskatchewan, Wenzel focuses on youth degenerative brain disease and the limits of traditional research models.
He grows human brain organoids — “mini brains” — from pluripotent stem cells derived from sources like blood or skin. Measuring two millimetres apiece, those organoids resemble tiny blobs of chewing gum.
“We will turn [cells from a patient] into pluripotent stem cells, and we will make their mini brain, and because it has their genetic information, we get a brain that has their pathology,” Wenzel said.
“If you do that same mutation, often in a mouse, the pathology won't appear. So it allows us to actually get a pathology we can actually study,” he said.
When Wenzel was first hired at the University of Saskatchewan in 2024, the budget-conscious researcher built his lab on a shoestring, picking up secondhand centrifuges, balances, fridges and freezers from industrial start-ups. That move saved him time, and hundreds of thousands of dollars.
"All the money that we started off with, it is literally going to just the research team and directly to the research," Wenzel said, crediting NSERC and SHRF for their support. "I am so grateful."
Today, Wenzel studies childhood cerebral X-linked adrenoleukodystrophy (ALD), a rare degenerative brain disease that strikes children, and is fatal when left untreated. His organoids may provide proof of concept for new ways to target the brain and nervous system, without the need for radiation, chemotherapy, and lifelong immunosuppresant drugs currently required for hematopoietic stem cell transplants.
“Chemotherapy and irradiation makes holes throughout your whole body. So we can do it in just your brain, just your spinal cord, and then we can inject the immune cells specifically into those locations,” Wenzel said. “That eliminates many of the things that make chemotherapy uncomfortable, many of the things that make any sort of stem cell transplant uncomfortable.”
This spring, Canada’s Stem Cell Network singled out Wenzel’s work with a Rising Star Award, saying his work demonstrates "leadership, creativity and potential for major impact".
If his method shows promise in treating ALD, Wenzel’s approach could pave the way for more targeted, effective and far less invasive treatments for a range of degenerative brain diseases.